Body composition and echocardiographic abnormalities associated to anemia and volume overload in heart failure patients

Clinical Nutrition

Volumn 25, Issue 5, 2006, Pages 746-757

  Colín Ramírez, Eloisa ^a   Castillo Martínez, Lilia ^a   Orea Tejeda, Arturo ^a   Asensio Lafuente, Enrique ^a   Torres Villanueva, Fabiola ^a   Rebollar González, Verónica ^a   Narváez David, Rene ^a   Dorantes García, Joel ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Anemia; Heart failure; Volume overload

Indexed keywords

ALBUMIN; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; LOOP DIURETIC AGENT; NITRATE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BODY COMPOSITION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLE; DISEASE ASSOCIATION; ECG ABNORMALITY; EXTRACELLULAR FLUID; FEMALE; FUNCTIONAL STATUS; HAND GRIP; HEART FAILURE; HEART LEFT ATRIUM; HEMATOCRIT; HUMAN; IMPEDANCE; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PREVALENCE; QUALITY OF LIFE; SYSTOLE; WAIST HIP RATIO;

ANEMIA; ANTHROPOMETRY; BLOOD VOLUME; BODY COMPOSITION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ELECTRIC IMPEDANCE; FEMALE; HAND STRENGTH; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE;

EID: 33748907013     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2006.01.009     Document Type: Article

References (28)

1. Felker G.M., Adams Jr. K.F., Gattis W.A., and O'Connor C.M. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 (2004) 959-966
2. Wexler D., Silverberg D., Sheps D., et al. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. Int J Cardiol 96 (2004) 79-87
3. Wexler D., Silverberg D., Sheps D., and Iaina A. The importance of correction of anemia with erythropoietin and intravenous iron in severe resistant congestive heart failure. Eur J Heart Failure Suppl 2 (2003) 225-230
4. Silverg D., Wexler D., and Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Failure 4 (2002) 681-686
5. Anand I., McMurray J.J., Whitmore J., et al. Anemia and its relationship to clinical outcome in heart failure. Circulation 110 (2004) 149-154
6. Horwich T.B., Fonarow G.C., Hamilton M.A., MacLellan W.R., and Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39 (2002) 1780-1786
7. Maggioni A.P., Latini R., Anand I., et al. Prevalence and prognostic role of anemia in patients with heart failure in the IN-CHF Registry and the Val-HeFT trial. Eur Heart J 4 Suppl (2002) (Abstract 1480)
8. Szachniewicz J., Petruk-Kowalczyk J., Majda J., et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 90 (2003) 303-308
9. Bolger A.P., Doehner W., Sharma R., Coats J.S., and Anker S. Anemia in chronic heart failure: the relationship to inflammatory cytokine production and prognosis importance. Circulation 106 Suppl. (2002) 2819A
10. Sharma R., Francis D.P., Pitt B., Poole-Wilson P.A., Coats A.J., and Anker S.D. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 25 (2004) 1021-1028
11. Androne A.S., Katz S.D., Lund L., et al. Hemodilution is common in patients with advanced heart failure. Circulation 107 (2003) 226-229
12. Witte K.K., Desilva R., Chattopadhyay S., Ghosh J., Cleland J.G., and Clark A.L. Are hematinic deficiencies the cause of anemia in chronic heart failure?. Am Heart J 147 (2004) 924-930
13. Kalra P.R., Anagnostopoulos C., Bolger A.P., Coats A.J., and Anker S.D. The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol 39 (2002) 1901-1908
14. Bioelectrical impedance method in clinical research: a follow-up to the NIH technology assessment conference. Nutrition 15 (1999) 874-880
15. Piccoli A, Pastori G. BIVA Software. Department of Medical and Surgical Sciences, University of Padova, Padova, Italy, 2002 (Available at E-mail: apiccoli@inipd.it).
16. The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure (update 2005). Eur Heart J 2005;26:1115-40.
17. World Health Organization. Nutritional anaemias: report of a WHO scientific group. World Health Organ Tech Rep Ser 405 (1968) 3-37
18. Lohman T.G., Roche A.F., and Martorell R. Anthropometric standardization reference manual, abridged ed (1991), Human Kinetics Books, Champaing, IL
19. Hannan W.J., Cowen S.J., Plester C.E., Fearon K.C.H., and Debeau A. Comparison of bio-impedance spectroscopy and multi-frequency bio-impedance analysis for the assessment of extracellular and total body water in surgical patients. Clin Sci (London) 89 (1995) 651-658
20. Campbell I.T., Han, Bolton M., Nightingale P., Columb M.O., and Brookes S.J. The use of multiple frequency bioimpedance to assess fluid balance in critical illness. Proc Nutr Soc 53 (1998) 62A
21. Paterna S., Pasquale P.D., Parrinello G., et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure. A double-blind study. J Am Coll Cardiol 45 (2005) 1997-2003
22. Green C.P., Porter C.B., Bresnahan D.R., and Spertus J.A. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. JACC 35 (2000) 1245-1255
23. Rector T.S., and Cohn J.N. Assessment of patients outcome with the Minnesota Living with Heart Failure Questionnaire: reliability and validity during a randomised, double-blind, placebo-controlled trial of pimobendan. Am Heart J 124 (1992) 1017-1025
24. Rector T.S., Kubo S.K., and Cohn J.N. Patient's self-assessment of their congestive heart failure, II: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire. Heart Failure 3 (1987) 198-209
25. Rauchhaus M., Clark A.L., Doehner W., et al. The relationship between cholesterol and survival in patients with chronic Herat failure. JACC 42 (2003) 1933-1940
26. Maggiore Q., Nigrelli S., Ciccarelli C., Grimaldi C., Rossi G.A., and Michelassi C. Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int 50 (1996) 2103-2108
27. Schwenk A., Beisenherz A., Römer K., Kremer G., Salzberger B., and Elia M. Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr 72 (2000) 496-501
28. Guglielmi F.W., Mastronuzzi T., Pietrini L., Panarese A., Panella C., and Francavilla A. The RXc Graph in evaluating and monitoring fluid balance in patients with liver cirrhosis. Ann NY Acad Sci 873 (1999) 105-111